Latest Data & Signals Issued

Below are some of the latest signals issued for uniQure N.V.

General

Signal Type Signal Value Data
Score 1.400 36 days ( -122.51 %
Last Price $44.39 -4.10 %
Performance History
7 Days
$27.87 $44.39
59.28%
30 Days
$24.19 $44.39
83.51%
12 Mos
$14.21 $44.39
212.39%

9/18

Active Buy Signals

Specific Signals

Short Term
Net score: 61.54
Signal Type Signal Value Importance Data
High / Low Buy Very Low $43.85 - $48.06
Position: 12.83% from low / 87.17% from high · Momentum: 63.08%
Trend - 3 mos 71.94 % High Width: 74.49 %
Pred. range - 3 mos $48.11 - $83.94 Low 8.37 % - 89.10 %
Volume Direction Sell High Volume: 5,081,906 · Direction: 0
Pivot Short Sell Very Low Jun 17, 2026 - 3 days
RSI Short Pivot Signal Sell Very Low Jun 17, 2026 - 3 days
Short MA 3 mos Sell Low Jun 15, 2026 - 5 days
Long MA 3 mos Buy Medium Apr 10, 2026 - 50 days
Short/Long MA 3 mos Buy Medium Apr 08, 2026 - 52 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 54.72
Signal Type Signal Value Importance Data
Trend - 12 mos -0.301 % Very High Width: 685.85 %
Pred. range - 12 mos $8.94 - $70.24 High -79.86 % - 58.24 %
Short MA 12 mos Sell Very High Jun 04, 2026 - 12 days
Long MA 12 mos Buy Very High May 01, 2026 - 35 days
Short/Long MA 12 mos Buy Very High May 12, 2026 - 28 days
Pivot Long Sell Low Oct 29, 2025 - 161 days
RSI Long Pivot Signal Sell Low Jun 17, 2026 - 3 days
Bollinger Buy Medium Apr 30, 2026 - 36 days
MACD Buy High No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Click to get the best stock tips daily for free!
ABOUT UNIQURE N.V.
uniQure N.V
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE